CORC

在结果中检索

CORC

浏览/检索结果: 共33条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
RATIONALE 001: Tislelizumab (BGB-A317) 1 concurrent chemoradiotherapy (cCRT) followed by tislelizumab monotherapy in patients (pts) with newly diagnosed locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC) 会议论文
ANNALS OF ONCOLOGY, 2019-04-01
作者:  Paz-Ares, L.;  Senan, S.;  Planchard, D.;  Wang, L.;  Cheong, A.
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Primary results from TAIL, a global single-arm safety study of atezolizumab (atezo) monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer (NSCLC) 会议论文
44th Congress of the European-Society-for-Medical-Oncology (ESMO), SEP 27-OCT 01, 2019
作者:  Ardizzoni, A.;  Azevedo, S.;  Rubio Viquiera, B.;  Rodriguez Abreu, D.;  Alatorre-Alexander, J.
收藏  |  浏览/下载：16/0  |  提交时间：2019/12/31
Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 会议论文
作者:  Senkus-Konefka, E.;  Domchek, S. M.;  Im, S. A.;  Xu, B.;  Armstrong, A.
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05
OLAPARIB MAINTENANCE MONOTHERAPY IMPROVES PROGRESSION-FREE SURVIVAL (PFS) IN PATIENTS WITH PLATINUM-SENSITIVE RELAPSED OVARIAN CANCER (PSROC): SOLO2 STUDY - CHINA COHORT 会议论文
作者:  Liu, J.;  Yin, R.;  Wu, L.;  Zhu, J.;  Lou, G.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Efficacy and safety of once weekly dulaglutide monotherapy compared to glimepiride monotherapy in Chinese patients with type 2 diabetes mellitus who were oral antihyperglycemic medication naive: A post hoc analysis of a phase 3 randomized, double-blind study 会议论文
作者:  Li, Yiming;  Du, Liying;  Hou, Jianing
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Atezolizumab monotherapy in Chinese patients with locally advanced or metastatic solid tumours 会议论文
作者:  Shen, L.;  Zhang, L.;  Hu, X.;  Pan, H.;  Liu, T.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Pamiparib, a novel PARP 1/2 inhibitor, monotherapy for gBRCAm patients with recurrent ovarian, fallopian, and primary peritoneal cancer: An open-label, multicenter, phase II trial in China 会议论文
作者:  Wu, X.;  Wang, J.;  Zhou, Q.;  Gu, T.;  Zhang, K.
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
Treatment efficacy and glucose variability control of exenatide versus biphasic insulin aspart 30 in Chinese patients with type 2 diabetes inadequately controlled with metformin monotherapy: a multicenter, randomized, open-label, parallel study 会议论文
作者:  Liu, Xiangyang;  Ji, Qiuhe;  Yang, Wenjuan;  Liu, Jianrong;  Gao, Xiling
收藏  |  浏览/下载：4/0  |  提交时间：2019/11/19
Olaparib monotherapy versus chemotherapy for patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: Asian subgroup analysis from the phase III OlympiAD trial 会议论文
CANCER RESEARCH, 2018-02-01
作者:  Im, Seock-Ah;  Xu, Binghe;  Li, Wei;  Robson, Mark;  Ouyang, Quchang
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD 会议论文
EUROPEAN JOURNAL OF CANCER, 2018-04-01
作者:  Senkus-Konefka, E.;  Domchek, S. M.;  Im, S. A.;  Xu, B.;  Armstrong, A.
收藏  |  浏览/下载：16/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace